NEW YORK STATE COMMON RETIREMENT FUND - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 72 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$823
+100.7%
27,681
+21.7%
0.00%0.0%
Q2 2023$410
-11.3%
22,739
-20.9%
0.00%0.0%
Q1 2023$462
-35.5%
28,764
-26.5%
0.00%0.0%
Q4 2022$716
-99.9%
39,120
-0.1%
0.00%0.0%
Q3 2022$769,000
+21.3%
39,148
+15.2%
0.00%0.0%
Q2 2022$634,000
-8.1%
33,992
+8.2%
0.00%0.0%
Q1 2022$690,000
-7.8%
31,421
+19.4%
0.00%0.0%
Q4 2021$748,000
+34.8%
26,317
-0.3%
0.00%0.0%
Q3 2021$555,000
-6.6%
26,387
-16.3%
0.00%0.0%
Q2 2021$594,000
+56.7%
31,522
+27.1%
0.00%
Q1 2021$379,000
+8.3%
24,8000.0%0.00%
Q4 2020$350,000
-10.0%
24,8000.0%0.00%
Q3 2020$389,000
-10.4%
24,8000.0%0.00%
-100.0%
Q2 2020$434,000
+132.1%
24,800
+95.3%
0.00%
Q1 2020$187,000
-41.4%
12,7000.0%0.00%
Q4 2019$319,000
+67.0%
12,7000.0%0.00%
Q3 2019$191,000
-39.9%
12,7000.0%0.00%
Q2 2019$318,000
+241.9%
12,700
+209.8%
0.00%
Q1 2019$93,000
-24.4%
4,1000.0%0.00%
Q4 2018$123,0004,1000.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Saturn V Capital Management LP 623,819$11,336,5019.41%
Finepoint Capital LP 822,745$15,0564.87%
Bain Capital Life Sciences Investors, LLC 2,305,558$42,1924.72%
Opaleye Management Inc. 732,000$13,395,6004.66%
5AM Venture Management, LLC 862,286$15,779,8344.24%
SPHERA FUNDS MANAGEMENT LTD. 671,644$12,291,0852.64%
First Light Asset Management, LLC 1,329,313$24,326,4282.26%
BRAIDWELL LP 3,469,674$63,495,0342.13%
BVF INC/IL 2,736,613$50,080,0182.11%
Perceptive Advisors 4,039,276$73,918,7512.08%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders